From March 30 to 31, the 7th China Medicine and Health Digital Technology Conference 2023 was successfully held in Shanghai. As a leading enterprise intelligent network service provider, Guanglian and 350+ medical and health industry executives, CIO and industry excellent information service providers were invited to attend this event to discuss innovative technology and explore the future development trend of medicine.

In recent years, with the deep integration of the new generation of information technology and biomedicine, digital technologies such as 5G communication, artificial intelligence, big data, and cloud computing are bringing disruptive innovations to the pharmaceutical and health industry. Under the new market opportunity, the theme of this conference is "2023: Accelerating the construction of data-driven smart enterprises", and discusses how pharmaceutical and health enterprises can fully empower their own growth through digital transformation from many aspects, such as industry best practices, technology development trends, and transformational value discovery.
At present, the digitization process of the biomedical industry is accelerating. However, while enterprises continue to improve the innovation ability of medical services and build digital medical services characterized by intelligence to advance in the industry track, enterprise networks are faced with problems such as high link cost, low bandwidth utilization, poor access experience for key services, and difficult unified operation and maintenance management of equipment.

In view of how pharmaceutical companies should combine their own advantages, consolidate the underlying network infrastructure, and accelerate the digital strategic layout, optical connectivity through customized SD-WAN intelligent networking services to help pharmaceutical companies achieve simple network management, security defense, bandwidth enhancement and application access optimization, etc. Let the medical and health industry experience an efficient, safe and stable network.

At this summit, the Guanglian exhibition area attracted many guests to exchange and discuss medicine-related solutions. SD-WAN Intelligent networking to build a high-speed, robust, secure intelligent network system, a multi-purpose network, improve network bandwidth utilization, reduce line costs, simplify operation and maintenance, can better help biomedical enterprises to achieve research and development, production, circulation, management and other aspects of the data security interconnection.

Improve efficiency and reduce cost: Optimize the original line, reduce link cost, and improve bandwidth.
Security guarantee: Achieve refined authority management to ensure enterprise information security.
Intelligent operation and maintenance: centralized and unified policy delivery, active fault prediction and online inspection.

Network connection is the foundation of digital transformation of enterprises. At present, Guanglian intelligent network service has successfully provided a solid network foundation support for well-known biopharmaceutical enterprises such as Boteng, Kunling Pharmaceutical, and Ingke Medical to implement digital strategy.